Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study


NAXOS aimed to compare the safety, effectiveness, and mortality of apixaban with vitamin K antagonists, rivaroxaban, and dabigatran, in oral anticoagulant-naive patients with nonvalvular atrial fibrillation.

Van Ganse E, Danchin N, Mahé I, et al. Stroke 2020;51(7):2066-2075.